USPH

U.S. Physical Therapy Inc. Common Stock (USPH)

Stock · NYSE · Health Care

$85.78as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

USPH Appoints New CFO and Board Member Amid Earnings Review. U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.

Active signals

Support level
$71.39
Industry
Medical/Nursing Services

What USPH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike24+0.3%50%
Bollinger Band Breakdown23-1.3%43%
Bollinger Band Breakout22+1.3%55%
200-Day Moving Average TouchActive now16-1.6%50%
Any 20-session window (baseline)+0.3%51%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About USPH

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-rel…

Sector
Health Care
Industry
Medical/Nursing Services
Employees
4,653

Fundamentals

1-day range
$84.23$87.41
Market cap
$1.16B
P/E (trailing)
39.50
P/E (forward)
25.67
EPS (trailing)
$2.13
Dividend yield
1.95%
Beta
1.13
Avg. volume
199.3K
Ex-dividend date
August 21, 2026
Dividend pay date
September 11, 2026
52-week range
$58.19$93.5
Next earnings: November 4, 2026 · EPS estimate $0.73confirmed

How U.S. Physical Therapy Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$780.99MNet Income$39.58M (5%)Other$652.34M (84%)SG&A$69.26M (9%)Tax$19.81M (3%)USPH

Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub

Gross Profit$149.69M(19%)
Operating Income$86.68M(11%)

Forecasts

6 analyst ratings

Buy 85%
Hold 15%
Sell 0%
1-year price forecast
High
$100
+16.6%
Median
$97
+13.1%
Low
$95
+10.7%

U.S. Physical Therapy Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • USPH
    U.S. Physical Therapy Inc. Common Stock
    $85.71
    ▼ 0.31%
    Market cap $1.16BP/E 39.50
    $58.19$93.5
  • OMDA
    Omada Health Inc. Common Stock
    $17.63
    ▼ 5.57%
    Market cap $1.16BP/E 265.49
    $10.28$26.92
  • LFMDP
    LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock
    $22.18
    ▲ 0.81%
    Market cap $1.12BP/E 589.89
    $2.36$6.53
  • TDOC
    Teladoc Health Inc. Common Stock
    $5.67
    ▼ 5.03%
    Market cap $1.21BP/E —
    $4.4$9.89
  • PNTG
    The Pennant Group Inc. Common Stock
    $41.87
    ▼ 0.95%
    Market cap $1.36BP/E 46.02
    $22.26$42.74
  • INNV
    InnovAge Holding Corp. Common Stock
    $8.85
    ▼ 1.45%
    Market cap $1.49BP/E —
    $3.94$12.64
  • AHCO
    AdaptHealth Corp. Common Stock
    $6.02
    ▼ 5.79%
    Market cap $824.20MP/E —
    $5.21$13.43

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
12.3K
Disposed
2.8K

Institutional Ownership

March 31, 2026

Total shares held
14.66M
Total value held
$1.06B
Institutional holders
219
Top holders this quarter
  • Unknown2.21M
  • Unknown1.07M
  • Unknown1.00M
  • Unknown836.8K
  • Unknown664.1K
  • Unknown648.4K
  • Unknown554.6K
  • Unknown507.4K
  • Unknown439.9K
  • Unknown400.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.